D&D Pharmatech Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-01.
D&D Pharmatech Inc. filed a Form D notice of an exempt securities offering with the SEC on August 1, 2025. The filing reports $10.80M sold. Its industry group is Pharmaceuticals. It names Seulki Lee (Executive Officer, Director), Sunghoon Hong (Executive Officer, Director), Sungmook Lim (Executive Officer, Director) (SEC Form D, August 1, 2025).
Is this your company?
Sell to companies like D&D Pharmatech Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns D&D Pharmatech Inc.
Free to see. No signup.
More on the people and the money behind D&D Pharmatech Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when D&D Pharmatech Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when D&D Pharmatech Inc. raises, hires or launches. No email unless you switch it on.
Watch D&D Pharmatech Inc. →Get the full cited report on D&D Pharmatech Inc.
What the filing shows about D&D Pharmatech Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on D&D Pharmatech Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives D&D Pharmatech Inc.'s address as 4TH Floor, 27, Geumto-Ro 80BEON-Gil, Sujeong-Gu, Seongnam-Si, M5 13454.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
D&D Pharmatech Inc. is a registered filer with the SEC (CIK 2077939) and has filed since 2025-08-01. 1 filing is on record, the latest on 2025-08-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
D&D Pharmatech Inc.'s Form D of 2025-08-01 names Seulki Lee, Sunghoon Hong, Sungmook Lim and 3 more as its officers, directors or promoters.
Its new offerings report $10.80M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Seulki Lee is named as Executive Officer and Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
Sunghoon Hong is named as Executive Officer and Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
Sungmook Lim is named as Executive Officer and Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
Daehyun Shin is named as Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
Seol-Heui Han is named as Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
Seungwon Lim is named as Director on the Form D that D&D Pharmatech Inc. filed with the SEC on 1 August 2025, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2025-08-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about D&D Pharmatech Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on D&D Pharmatech Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on D&D Pharmatech Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist D&D Pharmatech Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind D&D Pharmatech Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for D&D Pharmatech Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/d-d-pharmatech-inc-form-d-25000001